Quantum Biopharma (QNTM) Payables (2018 - 2026)
Quantum Biopharma (QNTM) posted Payables of $3.9 million for Q1 2026, down 29.02% sequentially from $5.5 million in Q4 2025, and up 12.98% YoY from $3.4 million in Q1 2025.
Quantum Biopharma (QNTM) Payables (2018 - 2026) Analysis & Trends
Quantum Biopharma has reported Payables for 9 years, with the latest figure at $3.9 million in Q1 2026.
- Quarterly Payables rose 12.98% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 12.98% YoY) and the FY2025 annual result came in at $5.5 million, up 10.07% from the prior year.
- Payables fell to $3.9 million in Q1 2026 per QNTM's latest filing, from $5.5 million in the prior quarter.
- Over five years, Payables peaked at $8.2 million in Q1 2022 and troughed at $3.4 million in Q1 2025.
- A 5-year average of $5.7 million and a median of $5.5 million in 2025 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2025: Payables sank 41.09% in 2023, then soared 68.02% in 2025.
- Over 5 years, Payables stood at $7.4 million in 2022, then slumped by 45.98% to $4.0 million in 2023, then gained by 24.45% to $5.0 million in 2024, then rose by 10.07% to $5.5 million in 2025, then declined by 29.02% to $3.9 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $3.9 million, $5.5 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Quantum Biopharma | 15.53 Mn | 11.89 Mn | - | 3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Mar 31, 2026 | 3.89 Mn |
| Dec 31, 2025 | 5.48 Mn |
| Sep 30, 2025 | 6.06 Mn |
| Jun 30, 2025 | 5.14 Mn |
| Mar 31, 2025 | 3.44 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 5.62 Mn |
| Mar 31, 2023 | 8.01 Mn |
| Dec 31, 2022 | 7.41 Mn |
| Sep 30, 2022 | 6.79 Mn |
| Jun 30, 2022 | 7.96 Mn |
| Mar 31, 2022 | 8.17 Mn |
| Dec 31, 2021 | 7.81 Mn |
| Sep 30, 2021 | 6.99 Mn |
| Jun 30, 2021 | 8.25 Mn |
| Mar 31, 2021 | 5.82 Mn |